时间依赖性扩散MRI微观结构参数在预测乳腺癌淋巴结转移中的效用
回顾性纳入109例术前行常规MRI及时间依赖性扩散MRI的乳腺癌患者,转移组56例、非转移组53例。转移组细胞内体积分数和细胞直径更高,ADC45Hz、ADC25Hz及ADCPGSE更低。细胞直径与ADC45Hz为独立预测因子,联合AUC 0.910,敏感度85.7%、特异度79.2%,并构建列线图,校准曲线一致性良好。
要点
- 转移组细胞内体积分数0.301±0.088、细胞直径13.999±1.962 μm,均高于非转移组。
- ADC45Hz单独诊断淋巴结转移AUC为0.892,为独立预测因子。
- 细胞直径联合ADC45Hz的AUC为0.910,敏感度85.7%、特异度79.2%。
核心结论
- 时间依赖性扩散MRI微观结构成像似乎是有望区分乳腺癌淋巴结转移状态的工具,细胞直径和ADC45Hz等独立参数可提供可靠指标支持临床决策与个体化治疗策略。
研究设计与样本
- 回顾性研究纳入109例术前行常规MRI及时间依赖性扩散MRI的乳腺癌患者,按病理分为淋巴结转移组56例与非转移组53例,采用IMPULSED方法估算微观结构参数。
关键影像表现/征象
- 转移组细胞内体积分数0.301±0.088,高于非转移组0.228±0.066(P<0.001)。
- 转移组细胞直径13.999±1.962 μm,高于非转移组12.069±2.331 μm(P<0.001)。
- 转移组ADC45Hz 1.174±0.133×10-3 mm2/s、ADC25Hz 1.057±0.141×10-3 mm2/s、ADCPGSE 0.790±0.128×10-3 mm2/s,均低于非转移组(P<0.001)。
- 观察者间ICC均高于0.85,提示可靠性优良。
诊断标准与关键数值
- ADC45Hz诊断淋巴结转移的AUC为0.892。
- 细胞直径联合ADC45Hz的AUC为0.910,敏感度85.7%、特异度79.2%。
- 基于独立危险因素构建列线图,校准曲线显示预测概率与观察概率一致性良好。
临床应用与阅片要点
- 时间依赖性扩散MRI可提供细胞直径、细胞内体积分数等微观结构参数,用于术前评估乳腺癌淋巴结转移状态。
- 细胞直径与ADC45Hz为独立预测因子,联合模型及列线图可辅助临床决策。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: This study aimed to evaluate the potential of time-dependent diffusion magnetic resonance imaging (td-dMRI) quantitative parameters in differentiating lymph node metastasis status in breast cancer patients.
METHODS: This retrospective study included 109 breast cancer patients who underwent preoperative magnetic resonance imaging (MRI), incorporating both conventional MRI and td-dMRI. Four microstructural parameters, including cell diameter, extracellular water diffusion coefficient, intracellular volume fraction, and cellular density, were estimated with the imaging microstructural parameters using limited spectrally edited diffusion (IMPULSED) method, along with three apparent diffusion coefficient (ADC) values at different frequencies. Patients were classified into lymph node metastatic (n = 56) and non-metastatic (n = 53) groups based on pathological findings. Quantitative MRI parameters were compared using Student's t-test or the Mann-Whitney U test. Binary logistic regression was used to identify independent predictors of lymph node metastasis, and receiver operating characteristic (ROC) curve analysis was performed to evaluate the model's performance. Independent predictive factors were identified, and a nomogram model was developed. The calibration of the model was subsequently evaluated by plotting a calibration curve. A P-value < 0.05 was considered statistically significant.
RESULTS: Td-dMRI parameters revealed significant differences, with the metastatic group showing a higher intracellular volume fraction (0.301 ± 0.088 vs. 0.228 ± 0.066; P < 0.001) and cell diameter (13.999 ± 1.962 μm vs. 12.069 ± 2.331 μm; P < 0.001). Additionally, the metastatic group exhibited significantly lower ADC45Hz, ADC25Hz, and ADCPGSE values (1.174 ± 0.133 × 10-3 mm2/s, 1.057 ± 0.141 × 10-3 mm2/s, and 0.790 ± 0.128 × 10-3 mm2/s, respectively) compared to the non-metastatic group (1.425 ± 0.167 × 10-3 mm2/s, 1.248 ± 0.192 × 10-3 mm2/s, and 1.031 ± 0.207 × 10-3 mm2/s; P < 0.001). ROC analysis yielded an area under the curve (AUC) of 0.892 for ADC45Hz. Binary logistic regression identified cell diameter and ADC45Hz as independent predictors of metastasis, achieving a combined AUC of 0.910, with a sensitivity of 85.7 % and specificity of 79.2 %. A nomogram was developed based on the identified independent risk factors, and the calibration curve indicated good agreement between the predicted and observed probabilities. Inter-observer intraclass correlation coefficient (ICC) values were all above 0.85, indicating excellent reliability.
CONCLUSIONS: Td-dMRI microstructural mapping is a promising tool for distinguishing lymph node metastasis status in breast cancer. Independent parameters such as cell diameter and ADC45Hz provide reliable metrics to support clinical decision-making and personalized treatment strategies.
引用
- Chen S, Bai J, Guo X, et al. Utility of time-dependent diffusion MRI based microstructural parameters in predicting lymph node metastasis in breast cancer. Eur J Radiol. 2025. PMID: 41242317. doi:10.1016/j.ejrad.2025.112515
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。